| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,218 |
Appendix 3X - Initial Director's Interest Notice
|
13 Oct 2026 11:43AM |
$6.920 |
$6.700 |
fallen by
3.18%
|
|
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$266 |
Change in substantial holding
|
13 Oct 2026 11:40AM |
$1.400 |
$1.420 |
risen by
1.43%
|
|
| The Australian Wealth Advisory Group Limited (WAG) ORDINARY FULLY PAID |
Financials |
$45 |
Notice of Annual General Meeting/Proxy Form
|
13 Oct 2026 11:38AM |
$0.600 |
$0.600 |
fallen by
0%
|
|
| G50 Corp Limited (G50) ORDINARY FULLY PAID |
Materials |
$81 |
Change of Director's Interests Notice - I Davies
|
13 Oct 2026 11:35AM |
$0.315 |
$0.325 |
risen by
3.17%
|
|
| Greenvale Energy Limited (GRV) ORDINARY FULLY PAID |
Energy |
$15 |
Change of Director's Interest Notice - NB
|
13 Oct 2026 11:29AM |
$0.023 |
$0.022 |
fallen by
4.35%
|
|
| Genesis Minerals Limited (GMD) ORDINARY FULLY PAID |
Materials |
$8,120 |
Ceasing to be a substantial holder from MUFG
|
13 Oct 2026 11:28AM |
$7.215 |
$6.910 |
fallen by
4.23%
|
|
| Liberty Financial Group (LFG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Financials |
$947 |
Notification regarding unquoted securities - LFG
|
13 Oct 2026 11:24AM |
$3.200 |
$3.120 |
fallen by
2.50%
|
|
| Hearts and Minds Investments Limited (HM1) ORDINARY FULLY PAID |
Financials |
$625 |
September Investment Update
|
13 Oct 2026 11:24AM |
$2.850 |
$2.730 |
fallen by
4.21%
|
|
| Liberty Financial Group (LFG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Financials |
$947 |
Notification of cessation of securities - LFG
|
13 Oct 2026 11:21AM |
$3.200 |
$3.120 |
fallen by
2.50%
|
|
| Terramin Australia Limited (TZN) ORDINARY FULLY PAID |
Materials |
$45 |
Application for quotation of securities - TZN
|
13 Oct 2026 11:21AM |
$0.019 |
$0.019 |
fallen by
2.63%
|
|
| Cleanaway Waste Management Limited (CWY) ORDINARY FULLY PAID |
Industrials |
$5,898 |
Notification regarding unquoted securities - CWY
|
13 Oct 2026 11:15AM |
$2.650 |
$2.630 |
fallen by
0.75%
|
|
| Viridis Mining and Minerals Limited (VMM) ORDINARY FULLY PAID |
Materials |
$501 |
Becoming a substantial holder from MUFG
|
13 Oct 2026 11:15AM |
$3.540 |
$3.110 |
fallen by
12.15%
|
|
| Terramin Australia Limited (TZN) ORDINARY FULLY PAID |
Materials |
$45 |
Notification regarding unquoted securities - TZN
|
13 Oct 2026 11:15AM |
$0.018 |
$0.019 |
risen by
2.78%
|
|
| Terra Metals Limited (TM1) ORDINARY FULLY PAID |
Materials |
$149 |
DATE OF AGM & CLOSING DATE FOR DIRECTOR NOMINATIONS
|
13 Oct 2026 11:15AM |
$0.195 |
$0.145 |
fallen by
25.64%
|
|
| Peninsula Energy Limited (PEN) ORDINARY FULLY PAID |
Energy |
$97 |
Retirement of Non-Executive Director
|
13 Oct 2026 11:07AM |
$0.190 |
$0.170 |
fallen by
10.53%
|
|
| Airtasker Limited (ART) ORDINARY FULLY PAID |
Communication Services |
$98 |
1Q27 Trading Update and Webinar
|
13 Oct 2026 11:06AM |
$0.185 |
$0.200 |
risen by
8.11%
|
|
| Energy Technologies Limited (EGY) ORDINARY FULLY PAID |
Industrials |
$12 |
Notification of cessation of securities - EGY
|
13 Oct 2026 11:04AM |
$0.020 |
$0.020 |
fallen by
0%
|
|
| Caspin Resources Limited (CPN) ORDINARY FULLY PAID |
Materials |
$28 |
Investor Webinar Presentation - Updated Kelpie MRE
|
13 Oct 2026 11:03AM |
$0.105 |
$0.095 |
fallen by
9.52%
|
|
| Energy Technologies Limited (EGY) ORDINARY FULLY PAID |
Industrials |
$12 |
Notification of cessation of securities - EGY
|
13 Oct 2026 10:58AM |
$0.020 |
$0.020 |
fallen by
0%
|
|
| Anatara Lifesciences Ltd (ANR) ORDINARY FULLY PAID |
Health Care |
$3 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
13 Oct 2026 10:58AM |
$0.009 |
$0.009 |
fallen by
0%
|
|
ANR - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers Q1 FY2027 for the quarter ended 30 September 2026.
- Anatara is progressing the Anti-Obesity Project by manufacturing a demonstration batch of compound AOC.
- The company decided further pre-clinical work is not required and a clinical trial is not essential to progress the commercial proposition.
- The planned demonstration batch is expected to be about 10,000 capsules for stability testing and registration for human use in sales and marketing.
- AOC is being developed as an oral complementary medicine to assist weight reduction and help maintain weight loss after stopping GLP-1 medicines such as semaglutide.
- Earlier pre-clinical studies showed statistically significant reduction in rebound weight gain after semaglutide cessation with p-score less than 0.019.
- Pre-clinical studies also showed a significant reduction in perigonadal fat weight with p=0.024.
- Mechanism-of-action studies were inconclusive regarding a direct effect on endogenous GLP-1 levels.
- The company has spent more than $350,000 on proof-of-concept studies for the Anti-Obesity Project.
- Anatara continues to assess additional strategic opportunities, including business development and M&A.
- There remains commercial interest in the GaRP project IP.
- GaRP pre-clinical work in an IBD mouse model and the IBS clinical trial manuscripts were submitted for review and publication.
- The 2026 R&D tax incentive registration was lodged with AusIndustry on 28 July 2026.
- The anticipated R&D tax rebate of $318,402 was received and announced in September 2026.
- Cash and cash equivalents at 30 September 2026 were $0.551 million, up from $0.471 million at 30 June 2026.
- Net cash from operating activities for the quarter was an inflow of $80,000.
- Operating cash receipts included $318,000 in government grants and tax incentives and $1,000 interest received.
- Operating cash payments included $2,000 for research and development, $1,000 for advertising and marketing, $71,000 for staff costs, and $175,000 for administration and corporate costs.
- There were no investing cash flows and no financing cash flows during the quarter.
- Payments to related parties totalled $56,000 and related mainly to directors’ fees and superannuation.
- The board agreed to reduce cash payment of directors’ fees to 60% until further notice, with the remaining 40% to be compensated through future equity issuance.
- The Appendix 4C was dated 13 October 2026 and authorised by the Board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| JPMorgan Global Research Enhanced Index Equity Active ETF (Managed Fund) (JREG) |
Financials |
$79 |
Outstanding ETF Securities and Monthly Redemptions
|
13 Oct 2026 10:55AM |
$88.850 |
$87.980 |
fallen by
0.98%
|
|
| Xero Limited (XRO) ORDINARY FULLY PAID |
Information Technology |
$9,850 |
Notification of cessation of securities - XRO
|
13 Oct 2026 10:54AM |
$60.400 |
$57.720 |
fallen by
4.44%
|
|
| La Trobe Private Credit Fund (LF1) ORDINARY UNITS FULLY PAID |
Financials |
$251 |
Update - Notification of buy-back - LF1
|
13 Oct 2026 10:53AM |
$1.870 |
$1.860 |
fallen by
0.53%
|
|
| Bailador Technology Investments Limited (BTI) ORDINARY FULLY PAID |
Financials |
$128 |
AGM Presentation and Chairman's Address
|
13 Oct 2026 10:47AM |
$0.870 |
$0.840 |
fallen by
3.45%
|
|
BTI - Price-sensitive ASX Announcement
Full Release
Key Points
- AGM presentation and Chairman’s Address were released on 13 October 2026.
- BTI reiterated its strategy of investing in high-growth expansion-stage technology companies at attractive valuations.
- FY26 follow-on investments totalled $7.6 million across DASH, Rosterfy and PropHero.
- BTI realised $28 million in cash in FY26, including a $25 million partial realisation of SiteMinder.
- The SiteMinder realisation was achieved at a 36.9% IRR.
- Private portfolio companies recorded weighted average revenue growth of 32% in FY26.
- The portfolio’s weighted average gross margin was about 63% and recurring revenue was about 82%.
- Gross portfolio gains for FY26 were $17.9 million, representing a 7.5% gross portfolio return.
- Profit after tax for FY26 was $6.9 million.
- Post-tax NTA was $1.61 per share at 30 June 2026.
- BTI declared a final dividend of 3.5 cents per share, with FY26 total dividends of 7.4 cents per share.
- The grossed-up annualised dividend yield on the final dividend was 9.5%.
- BTI targets returning 4% per annum of pre-tax NTA to shareholders through fully franked half-yearly dividends.
- Financial assets in the private portfolio increased to $209 million, while listed marketable securities declined after the SiteMinder realisation.
- Portfolio updates highlighted valuation growth in Updoc, PropHero, Hapana and MOSH.
- BTI stated the portfolio outperformed ASX technology indices in a challenging macro environment, though returns were below internal targets.
- BTI reported that its emissions were tracked and fully offset as part of its ESG reporting.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Theta Gold Mines Limited (TGM) ORDINARY FULLY PAID |
Materials |
$261 |
TGM Investor Presentation - Nordic Funds and Mines
|
13 Oct 2026 10:43AM |
$0.185 |
$0.190 |
risen by
2.70%
|
|